HIMS - Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
2024-05-21 09:21:57 ET
More on Eli Lilly, Novo Nordisk
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
- The FTC Cracks Down On Novo Nordisk's Ozempic
- Eli Lilly inks radiopharma deal worth up to $1.1B with Aktis
- Eli Lilly’s tirzepatide cleared for diabetes treatment in China